Global Challenge of Antibiotic-Resistant Treponema pallidum
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Syphilis is a multistage infectious disease that is usually transmitted through contact with active lesions of a sexual partner or from an infected pregnant woman to her fetus. Despite elimination efforts, syphilis remains endemic in many developing countries and has reemerged in several developed countries, including China, where a widespread epidemic recently occurred. In the absence of a vaccine, syphilis control is largely dependent upon identification of infected individuals and treatment of these individuals and their contacts with antibiotics. Although penicillin is still effective, clinically significant resistance to macrolides, a second-line alternative to penicillin, has emerged. Macrolide-resistant strains of Treponema pallidum are now prevalent in several developed countries. An understanding of the genetic basis of T. pallidum antibiotic resistance is essential to enable molecular surveillance. This review discusses the genetic basis of T. pallidum macrolide resistance and the potential of this spirochete to develop additional antibiotic resistance that could seriously compromise syphilis treatment and control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Update on acquired tetracycline resistance genes
Roberts, M. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.034 · Cited by 1,010
1993 Sexually Transmitted Diseases Treatment Guidelines
(1994) · Journal of School Health · doi:10.1111/j.1746-1561.1994.tb03287.x · Cited by 918
Lukehart, S. A., Hook, E. W., Baker-Zander, S. A., Collier, A. C., Critchlow, C. W., & Handsfield, H. H. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-11-855 · Cited by 603 · cited 2×
“) every 4 h or by continuous infusion for 10 to 14 days (4, 38, 78).”
BackgroundRolfs, R. T., Joesoef, M. R., Hendershot, E. F., Rompalo, A. M., Augenbraun, M. H., Chiu, M., Bolan, G., Johnson, S. C., French, P., Steen, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370504 · Cited by 550
Roberts, M. C. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01145.x · Cited by 392
Macrolide Resistance in Treponema pallidum in the United States and Ireland
Lukehart, S. A., Godornes, C., Molini, B. J., Sonnett, P., Hopkins, S., Mulcahy, F., Engelman, J., Mitchell, S. J., Rompalo, A. M., Marra, C. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040216 · Cited by 378 · cited 9×
“However, the recent, widespread syphilis epidemic in China, where syphilis had been virtually eliminated, and the resurgence of syphilis in many Western countries emphasize the urgent need for renewed vigilance (10, 11).”
BackgroundInfluentialSingle-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis.
Riedner, G., Rusizoka, M., Todd, J., Maboko, L., Hoelscher, M., Mmbando, D., Samky, E., Lyamuya, E., Mabey, D., Grosskurth, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044284 · Cited by 296
Marra, C. M., Boutin, P., McArthur, J. C., Hurwitz, S., Simpson, G., Haslett, J. P. A., van der Horst, C., Nevin, T., Hook, E. W., & AIDS Clinical Trials Group (ACTG) 145 Team (2000) · Clinical Infectious Diseases · doi:10.1086/313725 · Cited by 194
16S rRNA Mutation Associated with Tetracycline Resistance in a Gram-Positive Bacterium
Ross, J. I., Eady, E. A., Cove, J. H., & Cunliffe, W. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1702 · Cited by 194
Neurosyphilis and Penicillin Levels in Cerebrospinal Fluid
Mohr, J. A. (1976) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1976.03270200046031 · Cited by 178
Transplacental Passage of Erythromycin and Clindamycin
Philipson, A., Sabath, L. D., & Charles, D. (1973) · New England Journal of Medicine · doi:10.1056/nejm197306072882307 · Cited by 160 · cited 1×
“In the latter report, an infected pregnant woman treated with clindamycin, which has been shown to cross the placenta (55), gave birth to an infant with congenital syphilis.”
BackgroundAzithromycin-resistant syphilis infection: San Francisco, California, 2000–2004.
Mitchell, S. J., Engelman, J., Kent, C. K., Lukehart, S. A., Godornes, C., & Klausner, J. D. (2006) · Clinical Infectious Diseases · doi:10.1086/498899 · Cited by 137
HOOK, E. W., MARTIN, D. H., STEPHENS, J., SMITH, B. S., & SMITH, K. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200208000-00010 · Cited by 135
Doxycycline compared with benzathine penicillin for the treatment of early syphilis.
Ghanem, K. G., Erbelding, E. J., Cheng, W. W., & Rompalo, A. M. (2006) · Clinical Infectious Diseases · doi:10.1086/500406 · Cited by 125
Stamm, L. V., & Bergen, H. L. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.806-807.2000 · Cited by 123 · cited 2×
“Consistent with this hypothesis, Stamm and Bergen (71) demonstrated that an adenine (A)-to-guanine (G) transition, at the position cognate to A2058 in the Escherichia coli 23S rRNA gene, is present in both copies of the Street strain 14 23S rRNA gene (Table 1) (7).”
BackgroundSelf-citationCeftriaxone Therapy for Incubating and Early Syphilis
Hook, E. W., Roddy, R. E., & Hanosfield, H. H. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.881 · Cited by 88
Martin, I. E., Gu, W., Yang, Y., & Tsang, R. S. W. (2009) · Clinical Infectious Diseases · doi:10.1086/600878 · Cited by 85
Wong, T., Singh, A. E., & De, P. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.04.042 · Cited by 79
Smith, N. H., Musher, D. M., Huang, D. B., Rodriguez, P. S., Dowell, M. E., Ace, W., & White, A. C. (2004) · International Journal of STD & AIDS · doi:10.1177/095646240401500511 · Cited by 74
Ceftriaxone for Treatment of Primary Syphilis in Men: A Preliminary Study
MOORTHY, T. T., LEE, C.-T., LIM, K.-B., & TAN, T. (1987) · Sexually Transmitted Diseases · doi:10.1097/00007435-198704000-00013 · Cited by 52
A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy.
Zhou, P., Gu, Z., Xu, J., Wang, X., & Liao, K. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000170443.70739.cd · Cited by 49 · cited 2×
“pallidum were also to develop resistance to the tetracyclines, since there are few alternatives to penicillin, except for ceftriaxone, which has not been extensively tested in clinical settings (25, 40, 49, 68, 87).”
Background
Cited by
Peeling, R. W., Mabey, D., Kamb, M. L., Chen, X.-S., Radolf, J. D., & Benzaken, A. S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.73 · Cited by 664
Molina, J.-M., Charreau, I., Chidiac, C., Pialoux, G., Cua, E., Delaugerre, C., Capitant, C., Rojas-Castro, D., Fonsart, J., Bercot, B., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30725-9 · Cited by 449
2020 European guideline on the management of syphilis
Janier, M., Unemo, M., Dupin, N., Tiplica, G. S., Potočnik, M., & Patel, R. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16946 · Cited by 421
An Update on the Global Epidemiology of Syphilis
Kojima, N., & Klausner, J. D. (2018) · Current Epidemiology Reports · doi:10.1007/s40471-018-0138-z · Cited by 379
2014 European guideline on the management of syphilis
Janier, M., Hegyi, V., Dupin, N., Unemo, M., Tiplica, G. S., Potočnik, M., French, P., & Patel, R. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12734 · Cited by 360
Metadata
- Authors
- Stamm, L. V.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2010-02
- Volume
- 54
- Issue
- 2
- Pages
- 583-589
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2135648896
- Cited by
- 221
- References
- 22
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.